Systemic sclerosis treatment has advanced with new drugs targeting manifestations like alveolitis and pulmonary hypertension. Improved clinical trial methods aid in analyzing results and planning future research for this autoimmune disease.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Discussion:
Key Insights:
Outlook: